Key result
A 2-week treatment with Angiotensin-(1-7) normalized arterial pressure, reduced glycemia and triglyceridemia, improved proteinuria, and ameliorated structural alterations in the kidney of SHRSP.
Why the study?
Does Angiotensin-(1-7) reduce proteinuria and structural damage in salt-loaded stroke-prone spontaneously hypertensive rats?
Does Angiotensin-(1-7) reduce proteinuria and structural damage in salt-loaded stroke-prone spontaneously hypertensive rats?
Angiotensin-(1-7) demonstrates significant renoprotective and antihypertensive effects in a severe hypertensive rat model, highlighting its potential therapeutic role in hypertensive renal damage.
Answers are grounded in this paper and cite their sources.
Angiotensin-(1-7) shows no immediate clinical role; leaves open translation of renoprotective effects to human hypertensive kidney disease.
Angiotensin (ANG)-(1-7) constitutes an important functional end-product of the renin-angiotensin-aldosterone system that acts to balance the physiological actions of ANG II. In the kidney, ANG-(1-7) exerts beneficial effects by inhibiting growth-promoting pathways and reducing proteinuria. We examined whether a 2-wk treatment with a daily dose of ANG-(1-7) (0.6 mg·kg(-1)·day(-1)) exerts renoprotective effects in salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP). Body weight, glycemia, triglyceridemia, cholesterolemia, as well as plasma levels of Na+ and K+ were determined both at the beginning and at the end of the treatment. Also, the weekly evolution of arterial blood pressure, proteinuria, and creatinine clearance was evaluated. Renal fibrosis was determined by Masson's trichrome staining. Interleukin (IL)-6, tumor necrosis factor (TNF)-α, and nuclear factor-κB (NF-κB) levels were determined by immunohistochemistry and confirmed by Western blotting analysis. The levels of glomerular nephrin were assessed by immunofluorescence. Chronic administration of ANG-(1-7) normalized arterial pressure, reduced glycemia and triglyceridemia, improved proteinuria, and ameliorated structural alterations in the kidney of SHRSP as shown by a restoration of glomerular nephrin levels as detected by immunofluorescence. These results were accompanied with a decrease in both the immunostaining and abundance of IL-6, TNF-α, and NF-κB. In this context, the current study provides strong evidence for a protective role of ANG-(1-7) in the kidney.
No takes yet. Share an insight, caveat, or question.
Giani et al. (2010) studied Hypertension and renal damage. Angiotensin-(1-7) was evaluated on Renoprotective effects including arterial blood pressure, proteinuria, and structural alterations. A 2-week treatment with Angiotensin-(1-7) normalized arterial pressure, reduced glycemia and triglyceridemia, improved proteinuria, and ameliorated structural alterations in the kidney of SHRSP.
Synapse has enriched 10 related papers. Consider them for comparative context: